Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Randomized trial evaluating an mHealth intervention for the early community-based detection and follow-up of cutaneous leishmaniasis in rural Colombia

Open access
Castillo, Mabel, Alexander, Neal, Rubiano, Luisa, Rojas, Carlos, Navarro, Andrés, Rincon, Domiciano, Bernal, Leonardo Vargas, Lerma, Yenifer Orobio, Saravia, Nancy Gore, Aronoff-Spencer, Eliah · 2023 · PLOS Neglected Tropical Diseases

Abstract

Background: In Latin America, cutaneous leishmaniasis primarily affects dispersed rural communities, that have limited access to the public health system and medical attention. Mobile health (mHealth) strategies have shown potential to improve clinical management and epidemiological surveillance of neglected tropical diseases, particularly those of the skin. Methods: The Guaral +ST app for Android was designed to monitor cutaneous leishmaniasis treatment and assess therapeutic response. We carried out a randomized trial in the coastal municipality of Tumaco in southwestern Colombia, with parallel arms comparing a) follow-up aided by the app to b) standard institution-based follow-up. Treatment was prescribed according to national guidelines. Follow-up of therapeutic response was scheduled at the end of treatment and at 7, 13 and 26 weeks after the start of treatment. The primary endpoint was the proportion of participants who were monitored at or around week 26, allowing outcome and effectiveness of treatment to be determined. Results: Follow-up of treatment and outcome assessment was achieved in significantly more patients in the intervention arm than the controls, Of the 75 participants in the two randomized arms, 74 had information on whether or not treatment was followed and outcome determined at or around week 26. Among these, 26/49 (53.1%) were evaluated in the intervention arm, and none (0/25, 0%) in the control arm (difference = 53.1%, 95% confidence interval 39.1–67.0%, p<0.001). Of the 26 participants evaluated at or around week 26 in the intervention arm, 22 (84.6%) had cured. There were no serious adverse events, nor events of severe intensity among patients monitored by CHW using the app. Conclusion: This study provides proof of concept for mHealth to monitor treatment of CL in remote and complex settings, deliver improved care and to provide information to the health system on the effectiveness of treatment as it is delivered to affected populations. Clinical Trial Registration: ISRCTN54865992.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pntd.0011180

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Guaral +ST app. a) Initial screen of the app. b) Screen for registering the administered dose of treatment. c) Screen for registering injection site reactions. d) Lesion photographs registered via the app.
Fig 1 Guaral +ST app. a) Initial screen of the app. b) Screen for registering the administered dose of treatment. c) Screen for registering injection site reactions. d) Lesion photographs registered via the app.CC BY · PubMed Central
Fig 2 Study area. Tumaco municipality. The CIDEIM facility is in Tumaco town. During the study, participants had to reside in, or have access to, one of the three veredas shown as pink dots. Other names are of selected places of permanent residence of study participants. The international boundary is available from the GADM database of global administrative areas (https://gadm.org/download_country.html) under the licence shown at https://gadm.org/license.html. Locations were approximated from a map made by the United Nations Office for the Coordination of Humanitarian Affairs [26]. All are in Tumaco municipality except one (Barbacoas) shown as a solid black dot.
Fig 2 Study area. Tumaco municipality. The CIDEIM facility is in Tumaco town. During the study, participants had to reside in, or have access to, one of the three veredas shown as pink dots. Other names are of selected places of permanent residence of study participants. The international boundary is available from the GADM database of global administrative areas (https://gadm.org/download_country.html) under the licence shown at https://gadm.org/license.html. Locations were approximated from a map made by the United Nations Office for the Coordination of Humanitarian Affairs [26]. All are in Tumaco municipality except one (Barbacoas) shown as a solid black dot.CC BY · PubMed Central
Fig 3 CONSORT flowchart. The lower part, in grey, is a summary of the outcomes, based on all the timepoints.
Fig 3 CONSORT flowchart. The lower part, in grey, is a summary of the outcomes, based on all the timepoints.CC BY · PubMed Central
Fig 4 Kaplan-Meier survival. Proportion of patients who were followed over time in each group, showing that more app users were followed up at week 26.
Fig 4 Kaplan-Meier survival. Proportion of patients who were followed over time in each group, showing that more app users were followed up at week 26.CC BY · PubMed Central
Fig 5 Proportion of patients in each group who were followed over time and had a favorable (green) or unfavorable (red) therapeutic response. At target study week 26, this means treatment cure or failure. Before week 26 it means absence or presence of lesions. In the app arm approximately half of the participants have the information, while, in the control groups, only one person has the information at week 26.
Fig 5 Proportion of patients in each group who were followed over time and had a favorable (green) or unfavorable (red) therapeutic response. At target study week 26, this means treatment cure or failure. Before week 26 it means absence or presence of lesions. In the app arm approximately half of the participants have the information, while, in the control groups, only one person has the information at week 26.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 6

  1. Organización Panamericana de Salud, 2020, Leishmaniasis. Informe Epidemiológico de las Américas
  2. Corporación CIDEIM, 2018, Video Tutorial Guaral ST Inglés: YouTube
  3. Ministerio de Salud y Protección Social, Lineamientos para la Atención Clínica Integral de Leishmaniasis en Colombia., Bogotá, 2018
  4. Instituto Nacional de Salud, 2013, Lineamientos Para la Vigilancia y Control en Salud Pública 2013., Bogotá
  5. M Castro, 2014, Seguimiento de pacientes con leishmaniasis tegumentaria: experiencia en un centro de referencia., Infectio 18.
  6. United Nations Office for the Coordination of Humanitarian Affairs, 2016, Colombia: Municipio de Tumaco—Departamento de Nariño New York

Cited by

See all 7

Metadata

Authors
Castillo, M., Alexander, N., Rubiano, L., Rojas, C., Navarro, A., Rincon, D., Bernal, L. V., Lerma, Y. O., Saravia, N. G., & Aronoff-Spencer, E.
Affiliations
  • Centro Internacional de Entrenamiento e Investigaciones Medicas (CO)
  • Universidad de Antioquia (CO)
  • University of California San Diego (US)
Corresponding author
  • Saravia, Nancy Gore
  • Aronoff-Spencer, Eliah
Venue
PLOS Neglected Tropical Diseases
Published
2023-03-27
Volume
17
Issue
3
Pages
e0011180
ISSN
  • 1935-2727 (ISSN-L)
  • 1935-2735
OpenAlex
W4360995784
Cited by
7
References
19
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 1
FWCI
1.79
Type
journal article
Language
en
Open access
Locations
  • PLoS neglected tropical diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Greater South Information System
Funders
  • National Institutes of Health (TW009907 A1, D43 TW006589, U19AI129910)
  • Departamento Administrativo de Ciencia, Tecnología e Innovación (222956934763)
  • Special Programme for Research and Training in Tropical Diseases (2013/386736-0)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
Keywords
cutaneous leishmaniasis, mobile health, mobile health apps, community health workers, treatment follow-up, treatment response monitoring, rural health care, neglected tropical diseases
MeSH terms
Colombia, Follow-Up Studies, Humans, Rural Population, Leishmaniasis, Cutaneous, Telemedicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized trial evaluating an mHealth intervention for the early community-based detection and follow-up of cutaneous leishmaniasis in rural Colombia. https://app.cochat.ai/papers/10.1371/journal.pntd.0011180
The paper
Castillo, M., Alexander, N., Rubiano, L., Rojas, C., Navarro, A., Rincon, D., Bernal, L. V., Lerma, Y. O., Saravia, N. G., & Aronoff-Spencer, E. (2023). Randomized trial evaluating an mHealth intervention for the early community-based detection and follow-up of cutaneous leishmaniasis in rural Colombia. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011180

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.